查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813801

全球小分子 CDMO 市场：市场规模、份额和趋势分析（按产品、药物类型、应用和地区）、细分市场预测（2025-2033 年）

Small Molecule CDMO Market Size, Share & Trends Analysis Report By Product, By Drug Type, By Application, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

小分子CDMO市场概览

预计2024年全球小分子CDMO市场规模将达713亿美元，2033年将达到1,262亿美元，2025年至2033年的复合年增长率为6.7%。

市场成长是由策略外包趋势、强劲的药品管道和全球製造业转变的整合所推动的。

製药和生技公司越来越依赖CDMO来精简研发成本、加快上市时间，并充分利用其专业能力，尤其是在高活性原料药和复杂化学实体方面。小分子药物（尤其是在肿瘤、感染疾病和心血管疾病等治疗领域）的持续核准，支撑了对临床和商业规模生产的强劲需求。

这个市场由不断发展的医药创新和不断变化的药物开发经济状况所驱动。生物技术和虚拟製药公司的出现正在推动市场成长，而这些公司通常缺乏内部研发、扩大规模和 GMP 製造基础设施。这些公司不仅将 CDMO 作为供应商，还将他们作为策略合作伙伴，以便快速合规地将其分子推向市场。与过去外包以成本主导不同，如今的合约越来越以创新主导，依赖 CDMO 提供专业的製程化学、製剂科学和监管知识。这种转变在高价值小分子的开发中尤其明显，例如抗体药物复合体(ADC)、HPAPI 和标靶癌症治疗药物，这些药物面临高度的製造复杂性和对控制的需求。

此外，CDMO生态系统中数位化和先进製造技术的日益增长也促进了市场成长。人工智慧主导的预测模型、连续流处理和即时放行测试 (RTRT) 正在改变小分子製造的成本效益和灵活性。这些技术创新使CDMO能够在更快、数据丰富的环境中实现产品差异化、提高批量产量并满足品质要求。此外，大型製药公司正在寻求其供应链的永续性，这使得拥有绿色化学能力和低碳生产实践的CDMO成为更具吸引力的合作伙伴。由于地缘政治不稳定和药品短缺，供应链策略的区域转变也使市场受益，促使北美製药公司实现供应商基础多元化，并寻找拥有冗余产能的北美和欧洲CDMO。

目录

第一章 分析方法与范围

第二章执行摘要

第 3 章：小分子 CDMO 市场：驱动因素、趋势与范围

  • 市场联动展望
  • 小分子CDMO市场动态
  • 技术状况
  • 定价模式分析
  • 临床试验量分析
  • 小分子 CDMO 市场：分析工具

第四章 小分子 CDMO 市场：按产品分類的估计与趋势分析

  • 细分仪表板
  • 小分子CDMO市场：产品波动分析
  • 小分子 CDMO 市场：按产品分類的市场规模预测和趋势分析（2021-2033 年）
  • 活性药物成分（API）
  • 成品药品

第五章 小分子 CDMO 市场：依药物类型估算与趋势分析

  • 细分仪表板
  • 全球小分子CDMO市场：依药物类型分析波动
  • 全球小分子 CDMO 市场：按药物类型分類的市场规模预测和趋势分析（2021-2033 年）
  • 创新者
  • 学名药

第六章：小分子 CDMO 市场：依应用估算与趋势分析

  • 细分仪表板
  • 小分子CDMO市场：应用变化分析
  • 小分子 CDMO 市场：按应用分類的市场规模预测和趋势分析（2021-2033 年）
  • 瘤
  • 心血管疾病
  • 中枢神经系统 (CNS) 疾病
  • 自体免疫疾病/炎症
  • 其他的

第 7 章小分子 CDMO 市场：区域估计和趋势分析（按产品、药物类型和应用）

  • 区域市场仪表板
  • 全球市场概况：按地区
  • 市场规模预测及趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 公司分类
    • 市场领导
    • 新兴企业
  • 小分子 CDMO 市场占有率/估值分析（2024 年）
  • 公司简介
    • Lonza
    • Catalent, Inc.
    • Thermo Fisher Scientific Inc.
    • Cambrex Corporation
    • Bellen Chemistry
    • Siegfried Holding AG
    • Recipharm AB
    • Eurofins Scientific
    • Aurigene Pharmaceutical Services Ltd
    • CordenPharma International
Product Code: GVR-4-68040-165-6

Small Molecule CDMO Market Summary

The global small molecule CDMO market was estimated at USD 71.3 billion in 2024 and is projected to reach USD 126.2 billion by 2033, growing at a CAGR of 6.7% from 2025 to 2033. The growth of the market is due to a convergence of strategic outsourcing trends, robust pharmaceutical pipelines, and global manufacturing shifts.

Pharmaceutical and biotech companies increasingly rely on CDMOs to streamline R&D costs, accelerate time-to-market, and access specialized capabilities, particularly for highly potent APIs and complex chemistries. The consistent approval of small molecule drugs, especially in therapeutic areas such as oncology, infectious diseases, and cardiology, sustains strong demand for both clinical and commercial-scale manufacturing.

The market is driven by the evolving nature of pharmaceutical innovation and the changing economic landscape of drug development. The emergence of biotech firms and virtual pharma companies, which often lack in-house infrastructure for R&D, scale up, or GMP manufacturing, is driving the market growth. These companies are turning to CDMOs not just as suppliers but as strategic collaborators to bring their molecules to market quickly and compliantly. Unlike in the past where outsourcing was cost-driven, today's engagements are increasingly innovation-driven-relying on CDMOs for specialized process chemistry, formulation science, and regulatory knowledge. This shift is particularly evident in the development of high-value small molecules such as antibody-drug conjugates (ADCs), HPAPIs, and targeted oncology drugs, where manufacturing complexity and containment needs are high.

Moreover, the growing trend towards digitalization and advanced manufacturing technologies within the CDMO ecosystem is also contributing to market growth.AI-driven predictive modeling, continuous flow processing, and real-time release testing (RTRT) are transforming the cost-efficiency and flexibility of small molecule production. These innovations allow CDMOs to differentiate their offerings, improve batch yields, and meet quality requirements in a faster, more data-rich environment. In addition, large pharmaceutical companies are seeking sustainability in their supply chains, and CDMOs with green chemistry capabilities or low-carbon production practices are becoming more attractive partners. The market is also benefiting from regional shifts in supply chain strategy due to geopolitical instability and drug shortages-prompting Western pharma firms to diversify their supplier base and seek CDMOs in North America and Europe with redundant capacity.

Global Small Molecule CDMO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global small molecule CDMO market report based on product, drug type, application, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Active Pharmaceutical Ingredients (API)
  • Finished Drug Products
  • Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Innovators
  • Generics
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiovascular Disease
  • Central Nervous System (CNS) Conditions
  • Autoimmune/Inflammation
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Small Molecule CDMO Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Small Molecule CDMO Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trials Volume Analysis
  • 3.6. Small Molecule CDMO Market: Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Small Molecule CDMO Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Small Molecule CDMO Market Product Movement Analysis
  • 4.3. Global Small Molecule CDMO Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Active Pharmaceutical Ingredients (API)
    • 4.4.1. Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 4.5. Finished Drug Products
    • 4.5.1. Finished Drug Products Market Estimates and Forecasts, 2021 - 2033 (USD million)

Chapter 5. Small Molecule CDMO Market: Drug Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Small Molecule CDMO Market Drug Type Movement Analysis
  • 5.3. Global Small Molecule CDMO Market Size & Trend Analysis, by Drug Type, 2021 to 2033 (USD Million)
  • 5.4. Innovators
    • 5.4.1. Innovators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Generics
    • 5.5.1. Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Small Molecule CDMO Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Small Molecule CDMO Market Application Movement Analysis
  • 6.3. Global Small Molecule CDMO Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Cardiovascular Disease
    • 6.5.1. Cardiovascular Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Central Nervous System (CNS) Conditions
    • 6.6.1. Central Nervous System (CNS) Conditions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Autoimmune/Inflammation
    • 6.7.1. Autoimmune/Inflammation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Small Molecule CDMO Market: Regional Estimates & Trend Analysis by Product, Drug Type, Application

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Small Molecule CDMO Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Lonza
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Catalent, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Thermo Fisher Scientific Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Cambrex Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bellen Chemistry
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Siegfried Holding AG
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Recipharm AB
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Eurofins Scientific
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Aurigene Pharmaceutical Services Ltd
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CordenPharma International
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 5 North America Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 6 U.S. Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 7 U.S. Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 8 U.S. Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 9 Canada Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 10 Canada Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 11 Canada Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 12 Mexico Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 13 Mexico Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 14 Mexico Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 15 Europe Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 17 Europe Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 18 Europe Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 19 Germany Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 20 Germany Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 21 Germany Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 22 UK Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 23 UK Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 24 UK Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 25 France Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 26 France Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 27 France Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 28 Italy Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 29 Italy Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 30 Italy Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 31 Spain Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 32 Spain Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 33 Spain Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 34 Denmark Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 35 Denmark Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 36 Denmark Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 37 Sweden Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 38 Sweden Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 39 Sweden Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 40 Norway Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 41 Norway Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 42 Norway Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 47 China Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 48 China Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 49 China Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 50 Japan Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 51 Japan Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 52 Japan Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 53 India Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 54 India Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 55 India Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 56 South Korea Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 57 South Korea Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 58 South Korea Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 59 Australia Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 60 Australia Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 61 Australia Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 62 Thailand Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 63 Thailand Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 64 Thailand Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 65 Latin America Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 66 Latin America Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 67 Latin America Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 68 Latin America Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 69 Brazil Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 70 Brazil Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 71 Brazil Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 72 Argentina Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 73 Argentina Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 74 Argentina Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 75 MEA Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 76 MEA Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 77 MEA Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 78 MEA Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 79 South Africa Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 80 South Africa Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 81 South Africa Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 85 UAE Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 86 UAE Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 87 UAE Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 88 Kuwait Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Small Molecule CDMO market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Small Molecule CDMO market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Small Molecule CDMO market Product outlook: Segment dashboard
  • Fig. 22 Small Molecule CDMO market, by Product segment: Market share, 2025 & 2033
  • Fig. 23 Active Pharmaceutical Ingredients (API) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Finished Drug Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Small Molecule CDMO market Drug Type outlook: Segment dashboard
  • Fig. 26 Small Molecule CDMO market, by Drug Type segment: Market share, 2024 & 2033
  • Fig. 27 Innovators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Generics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Small Molecule CDMO market Application outlook: Segment dashboard
  • Fig. 30 Small Molecule CDMO market, by Application segment: Market share, 2024 & 2033
  • Fig. 31 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Cardiovascular Disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Central Nervous System (CNS) Conditions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Autoimmune/Inflammation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Regional market: Key takeaways
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 U.S. Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Canada Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Mexico Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Europe Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 UK Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Germany Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 France Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Italy Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Spain Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Denmark Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Sweden Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Asia Pacific Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Japan Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 China Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 India Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 South Korea Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Thailand Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Brazil Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Argentina Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 MEA Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 South Africa Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Saudi Arabia Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 UAE Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Market participant categorization
  • Fig. 90 Heat map analysis